Skip to main content
. 2014 Aug 25;6:92. doi: 10.1186/1758-5996-6-92

Table 2.

Prevalence of metabolic syndrome among groups

Treatment Prevalence P-value
1st Line drug treatment 15/62 (24.2%)
2nd Line drug treatment 5/50 (10%) 0.022*
Naïve 7/61 (11.5%)
Controls 4/50 (8%) χ2 = 9.6
Overall prevalence 31/223 (13.9%)

*Statistically significant.